AVUVX
Price
$14.51
Change
-$1.33 (-8.40%)
Updated
Apr 3 closing price
Net Assets
1.02B
VSCAX
Price
$20.55
Change
-$1.97 (-8.75%)
Updated
Apr 3 closing price
Net Assets
6.34B
Ad is loading...

AVUVX vs VSCAX

Header iconAVUVX vs VSCAX Comparison
Open Charts AVUVX vs VSCAXBanner chart's image
Avantis® U.S. Small Cap Value Instl
Price$14.51
Change-$1.33 (-8.40%)
VolumeN/A
Net Assets1.02B
Invesco Small Cap Value A
Price$20.55
Change-$1.97 (-8.75%)
VolumeN/A
Net Assets6.34B
AVUVX vs VSCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AVUVX vs. VSCAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVUVX is a StrongBuy and VSCAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 6.35B vs. AVUVX (1.02B). AVUVX pays higher dividends than VSCAX: AVUVX (1.49) vs VSCAX (0.37). AVUVX was incepted earlier than VSCAX: AVUVX (5 years) vs VSCAX (26 years). VSCAX (1.12) is less costly to investors than AVUVX (0.25). VSCAX is a more actively managed with annual turnover of: 40.00 vs. AVUVX (21.00). VSCAX has a lower initial minimum investment than AVUVX: VSCAX (1000) vs AVUVX (5000000). VSCAX annual gain was more profitable for investors over the last year : -1.20 vs. AVUVX (-5.27). VSCAX return over 5 years is better than : 216.20 vs. AVUVX (204.22).
AVUVXVSCAXAVUVX / VSCAX
Total Expense Ratio0.251.1222%
Annual Report Gross Expense Ratio0.251.1222%
Fund Existence5 years26 years-
Gain YTD-7.151-4.211170%
Front LoadN/A6%-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B6.35B16%
Annual Yield % from dividends1.490.37407%
Returns for 1 year-5.27-1.20438%
Returns for 3 years7.6813.8456%
Returns for 5 years204.22216.2094%
Returns for 10 yearsN/A9.77-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTTX12.85N/A
N/A
ICON Health and Information Tech Inv
BRXSX13.75N/A
N/A
MFS Blended Research Intl Eq R2
DGEYX20.42N/A
N/A
BNY Mellon Global Emerging Mkts - Y
GAOTX20.20N/A
N/A
JPMorgan Global Allocation R3
CBFFX36.62-0.68
-1.82%
American Funds Global Balanced 529F1